Bukhari Naeem, Joseph Joe P, Hussain Sayed Sajid, Khan Muhammad Adeeb, Wakim Marcel Jose Yibirin, Yahya Esam Bashir, Arif Amina, Saleem Afshan, Sharif Nadeem
Centre for Human Genetics, Hazara University Mansehra, Pakistan.
Department of Physiology and Biophysics, Case Western Reserve University School of Medicine, USA.
Asian Pac J Cancer Prev. 2019 Nov 1;20(11):3269-3277. doi: 10.31557/APJCP.2019.20.11.3269.
In current era of blue brain intelligence and technology access at ease, standardization of disease etiology demands extensive research to drop-down human papilloma virus associated head and neck squamous cell carcinomas impact at large. Present retrospection aims to estimate comparative association of human papilloma virus sub-genotypes in head and neck squamous cell carcinomas, critical analysis of existing research gap, treatment progress, co-infection, gender association, national status and challenges following Human papilloma virus led head and neck squamous cell carcinomas among world largest continent.
Head and neck squamous cell carcinomas are not just like malignancies of uterine cervix, lymph nodes and breast cancers. Human papilloma virus led head and neck squamous cell carcinomas treatment directly impact Central nervous system in humans. Intriguingly, human papilloma virus mediated immune response increases patient survival, which indirectly transmit human papilloma virus in future generations and act as a potential threat developing neurogenic disorders.
An objective based search strategy, following comprehensive and specific search approaches were made to retrieve recent 12 years research data from five different NCBI databases. Out of 300 shortlisted articles, only 24 principal studies met the inclusion criteria.
Highest human papilloma virus prevalence (10.42 %) was found in South Asia, 5.8 % in South East Asia, 5.7 % East Asia, 2.5% in west Asia and no relevant updated data was found from central Asian continent. Highest prevalence (10%) of HPV genotype-16 was recorded in Asia among 3, 710 enrolled cases including 2201 males, 1149 females and 360 cases of unknown gender. While undifferentiated multiple HPV genotype prevalence was 5.5 % (204 cases). Lowest percentage of HPV sub-types 68, 72, 57, 39 were recorded respectively. Pakistan ranked top reporting highest number of HPV-16 cases, Taiwan HPV-18, India HPV-31, Japan HPV-35 and Singapore in HPV-16 and HPV-18 co-infection rates respectively.
Exact prevalence of HPV associated head and neck squamous cell carcinomas among Asian population is still debatable. Due to higher heterogeneity (P< 0.00001), I2 = 81-88% at 95 % confidence interval), non-availability and limitations of reported studies from Asian sub-continents especially central Asia, western Asia and from south and south east Asia demand large scale collaborative research culture to standardize head and neck squamous cell carcinomas aetiology.
.
在当前蓝脑智能和技术触手可及的时代,疾病病因的标准化需要广泛研究,以大幅降低人乳头瘤病毒相关头颈部鳞状细胞癌的影响。本回顾旨在评估头颈部鳞状细胞癌中人乳头瘤病毒亚型的比较关联,对现有研究差距、治疗进展、合并感染、性别关联、国家状况以及人乳头瘤病毒导致的头颈部鳞状细胞癌在世界最大洲面临的挑战进行批判性分析。
头颈部鳞状细胞癌与子宫颈癌、淋巴结癌和乳腺癌等恶性肿瘤不同。人乳头瘤病毒导致的头颈部鳞状细胞癌治疗直接影响人类中枢神经系统。有趣的是,人乳头瘤病毒介导的免疫反应可提高患者生存率,这会间接将人乳头瘤病毒传播给后代,并成为引发神经源性疾病的潜在威胁。
采用基于目标的搜索策略,遵循全面和特定的搜索方法,从五个不同的NCBI数据库中检索最近12年的研究数据。在300篇入围文章中,只有24项主要研究符合纳入标准。
在南亚发现人乳头瘤病毒患病率最高(10.42%),东南亚为5.8%,东亚为5.7%,西亚为2.5%,未从中亚大陆获取到相关更新数据。在3710例纳入病例中,包括2201例男性、1149例女性和360例性别不明的病例,亚洲记录的HPV-16基因型患病率最高(10%)。而未分化的多种HPV基因型患病率为5.5%(204例)。分别记录到HPV亚型68、72、57、39的最低百分比。巴基斯坦报告的HPV-16病例数最多,台湾地区HPV-18病例数最多,印度HPV-31病例数最多,日本HPV-35病例数最多,新加坡HPV-16和HPV-18合并感染率最高。
亚洲人群中人乳头瘤病毒相关头颈部鳞状细胞癌的实际患病率仍存在争议。由于异质性较高(P<0.00001),在95%置信区间时I2 = 81 - 88%),亚洲次大陆尤其是中亚、西亚以及南亚和东南亚报告的研究缺乏可用性和存在局限性,因此需要大规模的合作研究文化来规范头颈部鳞状细胞癌的病因。